Mexico Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Mexico Blood Glucose Monitoring Market is Segmented Into Type (Self-Monitoring Blood Glucose and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, And Durables). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Mexico Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Mexico Blood Glucose Monitoring Market Size

View Global Report
Mexico Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 388.86 Million
Market Size (2030) USD 590.13 Million
CAGR (2025 - 2030) 8.70 %

Major Players

Mexico Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Mexico Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Mexico Blood Glucose Monitoring Market Analysis

The Mexico Blood Glucose Monitoring Market size is estimated at USD 388.86 million in 2025, and is expected to reach USD 590.13 million by 2030, at a CAGR of 8.7% during the forecast period (2025-2030).

Mexico is currently grappling with a major health crisis caused by the increasing prevalence of diabetes among its population. Recent data from the International Diabetes Federation (IDF) reveals that Mexico ranks among the countries with the highest rates of diabetes worldwide. The IDF's findings indicate that an estimated 15.2 million adults between the ages of 20 and 79 in Mexico are affected by diabetes, representing approximately 10.3% of the adult population. This concerning prevalence underscores the critical need for comprehensive strategies to combat the diabetes epidemic in the nation.

Various factors contribute to the elevated rates of diabetes in Mexico. Factors such as rapid urbanization, shifting dietary habits, and sedentary lifestyles have resulted in a rise in obesity rates, a significant risk factor for type 2 diabetes. Additionally, genetic predisposition, socioeconomic inequalities, and limited access to healthcare services further compound the issue, particularly affecting marginalized communities.

As the prevalence of diabetes continues to increase in Mexico, the demand for blood glucose devices is also on the rise. This trend is driving the growth of the blood glucose devices market in the country, as more individuals are in need of monitoring their blood sugar levels regularly.

Overall, the increasing prevalence of diabetes in Mexico is driving the growth of the blood glucose devices market in the country, as more individuals are seeking effective solutions to manage their condition and improve their quality of life. This trend is expected to continue in the coming years, as the healthcare industry focuses on addressing the challenges posed by the rising burden of diabetes in Mexico.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Mexico Blood Glucose Monitoring Industry Overview

The blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by major players like Dexcom, Medtronics, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped companies to strengthen their market presence.

Mexico Blood Glucose Monitoring Market Leaders

  1. Roche

  2. Abbott

  3. Medtronics

  4. Dexcom

  5. LifeScan

  6. *Disclaimer: Major Players sorted in no particular order
Mexico Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Mexico Blood Glucose Monitoring Market News

  • October 2023: Phillips-Medisize, a Molex company, is a prominent player in the pharmaceutical drug delivery, invitro diagnostic, and medtech devices industry. They have partnered with GlucoModicum, an inventive medtech company from Finland, to develop and bring to market an exclusive non-invasive, wearable device that addresses obstacles in continuous glucose monitoring (CGM) for both technology and patient care
  • March 2022: DexCom announced the receipt of a CE Mark for its G7 CGM system in Europe, intended for people who have diabetes and are two years and older, including pregnant women. With this approval, the highly popular and best-selling real-time CGM in the world is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app.

Mexico Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring blood glucose devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous blood glucose monitoring devices
    • 5.2.1 Sensors
    • 5.2.2 Durables (Receivers and Transmitters)

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Trivida Functional Medicine
    • 7.1.12 Senseonics
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Holding AG
    • 7.2.1.3 LifeScan
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Mexico Blood Glucose Monitoring Industry Segmentation

A blood glucose monitoring device consists of a handheld meter and disposable test strips. The user pricks their finger with a lancet to draw a small drop of blood, which is then applied to the test strip. The meter analyzes the blood sample and displays the glucose concentration in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L) on a digital screen. Mexico Blood Glucose Monitoring Market is segmented into Type and component. The report offers the value (in USD) and volume (in Units) for the above segments.

Self-monitoring blood glucose devices Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices Sensors
Durables (Receivers and Transmitters)
Need A Different Region or Segment?
Customize Now

Mexico Blood Glucose Monitoring Market Research FAQs

How big is the Mexico Blood Glucose Monitoring Market?

The Mexico Blood Glucose Monitoring Market size is expected to reach USD 388.86 million in 2025 and grow at a CAGR of 8.70% to reach USD 590.13 million by 2030.

What is the current Mexico Blood Glucose Monitoring Market size?

In 2025, the Mexico Blood Glucose Monitoring Market size is expected to reach USD 388.86 million.

Who are the key players in Mexico Blood Glucose Monitoring Market?

Roche, Abbott, Medtronics, Dexcom and LifeScan are the major companies operating in the Mexico Blood Glucose Monitoring Market.

What years does this Mexico Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the Mexico Blood Glucose Monitoring Market size was estimated at USD 355.03 million. The report covers the Mexico Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Mexico Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Mexico Blood Glucose Monitoring Industry Report

Statistics for the 2025 Mexico Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Mexico Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.